AdaptHealth (NASDAQ:AHCO) Hits New 12-Month Low - Here's Why

Shares of AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) reached a new 52-week low on Monday . The company traded as low as $7.40 and last traded at $7.59, with a volume of 824 shares traded. The stock had previously closed at $7.79.

Analysts Set New Price Targets

AHCO has been the subject of a number of recent research reports. Canaccord Genuity Group boosted their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. UBS Group dropped their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Truist Financial increased their price target on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Robert W. Baird upped their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. Finally, Royal Bank of Canada lifted their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $13.80.

AdaptHealth Stock Performance

The stock has a market cap of $1.13 billion, a price-to-earnings ratio of -5.10, a PEG ratio of 1.08 and a beta of 1.44. The firm has a fifty day simple moving average of $9.59 and a 200 day simple moving average of $9.88. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently made changes to their positions in the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the 4th quarter valued at $28,000. Blue Trust Inc. raised its holdings in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the last quarter. GAMMA Investing LLC lifted its position in AdaptHealth by 175.2% during the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after purchasing an additional 4,758 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after purchasing an additional 1,690 shares during the last quarter. Finally, Guggenheim Capital LLC grew its position in shares of AdaptHealth by 10.1% during the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after buying an additional 1,525 shares during the period. Institutional investors own 82.67% of the company's stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.